Back
Champions Oncology, Inc. 10K Form
Sell
49
CSBR
Champions Oncology, Inc.
Last Price:
$6.91
Seasonality Move:
56.88%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CSBR News And Ratings
See the #1 stock for the next 7 days that we like better than CSBR
CSBR Financial Statistics
Sales & Book Value
| Annual Sales: | $56.9M |
|---|---|
| Cash Flow: | $-2M |
| Price / Cash Flow: | 16.76 |
| Annual Sales: | $0.30 |
| Price / Book: | 22.34 |
Profitability
| EPS (TTM): | 0.16640 |
|---|---|
| Net Income (TTM): | $2.4M |
| Gross Margin: | $26.9M |
| Return on Equity: | 68.71% |
| Return on Assets: | 8.16% |
Champions Oncology, Inc. Earnings Forecast
Key Champions Oncology, Inc. Financial Ratios
-
The Gross Profit Margin over the past 28 years for CSBR is 47.27%.
-
The Selling, General & Administrative Expenses for CSBR have been equal to 29.65% of Gross Profit Margin.
-
The Research & Development expenses have been 11.99% of Revenue.
-
The Interest Expense is 0.57% of Operating Income.
-
The Net Earning history of CSBR is 8.26% of Total Revenues.
-
Per Share Earnings over the last 28 years have been positive in 12 years.
Champions Oncology, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | CSBR |
| CUSIP: | 15870P |
| Website: | championsoncology.com |
Debt
| Debt-to-Equity Ratio: | 1.3 |
|---|---|
| Current Ratio: | 0.96 |
| Quick Ratio: | 0.95 |
Price-to-Earnings
| Trailing P/E Ratio: | 20.36 |
|---|---|
| Forward P/E Ratio: | 67.1 |
CSBR Technical Analysis vs Fundamental Analysis
Sell
49
Champions Oncology, Inc. (CSBR)
is a Sell
Is Champions Oncology, Inc. a Buy or a Sell?
-
Champions Oncology, Inc. stock is rated a SellThe current Champions Oncology, Inc. [CSBR] share price is $6.71. The Score for CSBR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.